Welcome to our dedicated page for KT&G Corporation news (Ticker: KTCIY), a resource for investors and traders seeking the latest updates and insights on KT&G Corporation stock.
KT&G Corporation (KTCIY) delivers innovative tobacco products and Next Generation nicotine solutions through strategic global partnerships. This news hub provides investors with essential updates on corporate developments, manufacturing advancements, and market expansions.
Access timely reports on earnings announcements, product innovations in heat-not-burn technology, and international distribution agreements. Track governance updates including shareholder return initiatives and board nomination processes aligned with global best practices.
Our curated collection features press releases about factory operations, R&D breakthroughs in alternative nicotine delivery systems, and regulatory compliance achievements. Stay informed about strategic collaborations that enhance KT&G's position in 30+ international markets.
Bookmark this page for verified updates directly from corporate communications and trusted financial sources. Check regularly for new developments in KT&G's dual focus on traditional tobacco expertise and Next Generation Product leadership.
KT&G (KRX: 033780) successfully concluded its 38th annual general meeting, with shareholders approving all agenda items. The company increased its annual dividend to KRW 5,400 per share, up KRW 200 from the previous year, including an interim dividend of KRW 1,200.
Key approvals included amendments to the Articles of Incorporation, clarifying director numbers, audit committee member appointments, and president appointment methods. Sang-Hak Lee, Chief Operating Officer, was appointed as an inside director, while Kwan-Soo Shon and Jee-Hee Lee were re-appointed as outside directors.
During the company's 38th anniversary celebration, CEO Kyung-Man Bang highlighted the successful growth in global cigarette business profitability and announced plans to expand focus from traditional cigarettes to 'Modern Products' to adapt to market changes.
Korea Ginseng Corp (KGC), known for its JungKwanJang brand, has received the prestigious Tyler Award from the American Botanical Council (ABC) at the 2025 Natural Product Expo West on March 4. The award recognizes KGC's contributions to clinical research on natural products, particularly ginseng.
The company maintains global R&D centers and factories for efficacy research and product development, including a new R&D center near LA opened in March 2023 focused on developing health products for American consumers. KGC has also achieved KOLAS certification as an authorized testing agency for natural product safety analysis.
JungKwanJang currently holds the top position in the global herbal health supplement retail market according to Euromonitor International, distinguished by its tradition and quality control standards.
JungKwanJang, the global No.1 red ginseng brand, showcased its products at the 2025 Natural Products Expo West (NPEW), introducing new functional red ginseng solutions. The company unveiled three new sports-focused products in their 'Everytime' lineup:
- 'Everytime PowerForm' for endurance and stamina
- 'Everytime PerformA' for blood vessel expansion
- 'Everytime CaloTrim' for calorie burning
The products will be available on Amazon in March 2025. At NPEW, which attracts 3,000 companies from 130 countries and over 60,000 buyers, JungKwanJang also presented GLPro for blood sugar control and showcased seven KFDA-recognized functions of their red ginseng. The company received the Tyler Award from the American Botanical Council for their scientific research on ginseng benefits. JungKwanJang maintains its position as the leading brand in the global herbal health supplement retail market, according to Euromonitor International.
KT&G announced its 38th Annual General Meeting (AGM) scheduled for March 26, 2025, at the KT&G Human Resources Development Institute in Daejeon, South Korea. The meeting agenda includes approval of financial statements, partial amendments to articles of incorporation, appointment of directors, and director remuneration cap.
The Board recommended COO and Senior Executive VP Sang-Hak Lee as an inside director candidate, citing his role as CFO and contributions to increased profitability and establishment of shareholder policies. For outside director positions, Kwan-Soo Shon and Jee-Hee Lee have been nominated for another term. Shon, who served as CEO of CJ Logistics, has also been nominated as an audit committee member, while Lee, the CEO of W.WORKS, currently chairs the sustainability committee.
KT&G stated they are actively communicating with shareholders about strengthening business competitiveness and shareholder return plans while working to maximize stakeholder interests and corporate value.
KT&G reported strong financial results for 2024, with consolidated revenue reaching KRW 5.91 trillion (up 0.8% YoY) and operating profit of KRW 1.185 trillion (up 1.5% YoY). Under new CEO Kyung-man Bang's leadership, the tobacco segment showed impressive growth with revenue of KRW 3.906 trillion (up 8.1%) and operating profit of KRW 1.082 trillion (up 10.7%).
The company's global cigarette sales achieved a 10.3% YoY growth, with revenue reaching a record KRW 1.45 trillion. The Next Generation Product segment also showed positive trends, with domestic stick sales of 6.15 billion (up 7.7%) and global sales of 8.34 billion (up 1.5%).
KT&G announced significant shareholder returns, including immediate cancellation of treasury shares worth KRW 360 billion, planned share repurchases of KRW 300 billion, and total shareholder returns of KRW 1.1 trillion or higher for 2025. The company achieved a 12.2% ROE in 2024 and set growth targets of 5%+ for revenue and 6%+ for operating profit in 2025.
KT&G (KRX: 033780) celebrated the expansion of its Türkiye factory with a $60 million investment, installing two new high-tech manufacturing facilities. The expanded facility, now 25,000 square meters, features four cigarette-making machines with an annual capacity of 12 billion sticks. The expansion created 60 new jobs, bringing total employment to over 200 people.
The Türkiye factory, KT&G's first overseas facility established in 2008, will serve as a core manufacturing hub for exports to Northern African and Latin American markets. This expansion is part of KT&G's strategy to become a 'Global Top-tier' company, focusing on Next Generation Products, overseas cigarettes, and health functional foods. The company aims to increase its global revenue proportion to 50% by 2027.
KT&G's total investment in Türkiye now reaches $110 million, with additional factories under construction in Indonesia and Kazakhstan. The company operates through six global corporations and various branches worldwide.
KT&G (KRX:033780) has received strong credit ratings from major global agencies, with S&P assigning 'A-(Stable)' and Moody's assigning 'A3(Stable)' ratings. These ratings, which indicate high credit quality and very low credit risk, place KT&G among top-rated Korean companies excluding public enterprises and financial institutions.
The ratings reflect KT&G's dominant position in Korea's tobacco market, stable profit generation, and low financial leverage ratio. The agencies highlighted the company's success in Next Generation Products (NGP) and its diverse portfolio including ginseng products. They also noted KT&G's global expansion through new factories in Indonesia and Kazakhstan.
This follows the company's domestic 'AAA(Stable)' ratings from Korea's three major rating agencies in June 2023. KT&G maintains its commitment to financial stability and investment in core businesses as part of its 'leap to a Global Top-tier' vision.
JungKwanJang, Korea's leading red ginseng brand, has introduced two new products at Sprouts Farmers Market: 'Everytime Immune Support' and 'Korean Red Ginseng Extract Vital Tonic'. The company is expanding its presence in the US market with immunity and energy-focused supplements. The brand holds a 46.6% share in the global ginseng retail market and ranks first in herbal health supplements. The products align with 2024's health food trends focusing on botanical ingredients and energy functionality, with studies showing 48% of US consumers trust plant-based ingredients. JungKwanJang is also conducting scientific research at its Fullerton R&D center and offering BFCM promotions across various retail channels.
A study by Professor Narayanan Parameswaran's team at Michigan State University revealed that red ginseng effectively promotes bone and intestinal health through microbiota balance. The research, presented at the Korea Ginseng Society International Conference, showed that red ginseng consumption improved barrier function and bone density in mice with disrupted intestinal microflora. The study demonstrated increased diversity of beneficial intestinal bacteria and reduced leaky gut syndrome symptoms. Additionally, Korea's Ministry of Food and Drug Safety recently recognized red ginseng's ability to help control blood sugar levels, as proven through clinical research by JungKwanJang, the leading global ginseng retail brand for 10 consecutive years.
KT&G announced its 'Corporate Value-up Plan', targeting a 15% ROE by 2027, up from the current 10%. The company plans to return KRW 3.7 trillion to shareholders through 2027, including KRW 2.4 trillion in cash dividends and KRW 1.3 trillion in share buybacks. The plan includes streamlining Capex investment from KRW 3.5 trillion to KRW 2.4 trillion, while maintaining expected returns. KT&G will secure KRW 1 trillion through restructuring low-yield assets and plans to cancel 20% of outstanding shares by 2027. For 2023, the company approved an additional KRW 150 billion share buyback and cancellation, bringing total shareholder returns above 100%.
